← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phrixus Pharmaceuticals, Inc.
Ann Arbor, MI
$2,385,027
Total funding
6
Grants
Funding over time
peak $622.9K · FY2007–12$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,385,027 · 6
By mechanism
R43$2,078,319 · 5
R41$306,708 · 1
Investigators at Phrixus Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Treatment of Muscular Dystrophy-associated Dilated Cardiomyopathy with P-188$622,877
R43 · FY2012 · HL
Effects of P-188 on Respiratory Function and Diaphragm Degeneration in the mdx mo$583,225
R43 · FY2011 · NS
Development of Poloxamer-188 for the Treatment of Muscular Dystrophy Associated H$379,487
R43 · FY2009 · HL
Poloxamer 188 mechanism of action in ischemic heart failure.$306,708
R41 · FY2010 · HL
Poloxamer-188 for the prevention of fibrosis during peritoneal dialysis$277,646
R43 · FY2008 · DK
Chronic Treatment of Heart Failure With Poloxamer-188$215,084
R43 · FY2007 · HL